BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12391817)

  • 1. "Build it and they will come?".
    Giaquinta D
    Manag Care Interface; 2002 Oct; 15(10):44-5, 47. PubMed ID: 12391817
    [No Abstract]   [Full Text] [Related]  

  • 2. Responding to consumer demand for choice, flexibility.
    Brainerd M
    Healthplan; 2002; 43(4):13-7. PubMed ID: 12221770
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacy benefit starts to reflect push for consumer-directed care.
    Berberabe T
    Manag Care; 2003 Sep; 12(9):29-32. PubMed ID: 14528670
    [No Abstract]   [Full Text] [Related]  

  • 4. The state of consumer-centric care.
    Riddle C
    Manag Care Interface; 2002 Oct; 15(10):20-4. PubMed ID: 12391813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should you switch Medicare plans?
    Consum Rep; 2004 Sep; 69(9):51. PubMed ID: 15305428
    [No Abstract]   [Full Text] [Related]  

  • 6. The case against excessive cost sharing.
    Brixner DI
    Am J Manag Care; 2006 Apr; 12(6 Suppl):S162-4; discussion S167-72; quiz S173-6. PubMed ID: 16613531
    [No Abstract]   [Full Text] [Related]  

  • 7. But managed-care savings will grow--study.
    Kertesz L
    Mod Healthc; 1997 Jun; 27(23):8. PubMed ID: 10167938
    [No Abstract]   [Full Text] [Related]  

  • 8. Plans continue to raise copayments.
    Manag Care; 2005 Sep; 14(9):59. PubMed ID: 16238260
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary--How consumer-driven health care evolves in a dynamic market.
    Scandlen G
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1113-8. PubMed ID: 15230914
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary--Current MSA theory: well-meaning but futile.
    Halvorson GC
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1119-22. PubMed ID: 15230915
    [No Abstract]   [Full Text] [Related]  

  • 11. Managed care organizations: an introduction--Part II of II.
    Vogenberg FR
    Hosp Pharm; 1995 Feb; 30(2):138, 140-2. PubMed ID: 10184282
    [No Abstract]   [Full Text] [Related]  

  • 12. Defined-contribution products and their influence on pharmacy benefit management.
    Giaquinta D
    Manag Care Interface; 2003 Aug; 16(8):36-8. PubMed ID: 12964551
    [No Abstract]   [Full Text] [Related]  

  • 13. Bad tiered formulary designs yield poor outcomes, high cost.
    Sipkoff M
    Manag Care; 2004 Aug; 13(8):27, 31-2, 34-5. PubMed ID: 15457893
    [No Abstract]   [Full Text] [Related]  

  • 14. Consumer-directed health care: too good to be true?
    Cross M
    Manag Care; 2003 Sep; 12(9):18-25. PubMed ID: 14528669
    [No Abstract]   [Full Text] [Related]  

  • 15. The managed care prescription benefit. Challenged by shifting care and shifting costs.
    Bender J
    AAPPO J; 1991; 1(4):11-8. PubMed ID: 10149632
    [No Abstract]   [Full Text] [Related]  

  • 16. What you need to know about Medicare Part D.
    Consum Rep; 2006 Feb; 71(2):34-6. PubMed ID: 16509047
    [No Abstract]   [Full Text] [Related]  

  • 17. Mass customization--the next generation of pharmacy management.
    Chao S
    Am J Manag Care; 2003 Sep; Suppl Decison Maker News():5-7. PubMed ID: 14567452
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical formularies: the right formula for cost and utilization?
    Austin B
    Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
    [No Abstract]   [Full Text] [Related]  

  • 19. Rebates and other drug-cost issues.
    Penna P
    Manag Care Interface; 2003 May; 16(5):39-40. PubMed ID: 12789863
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary--Looking at the effects of consumer-centric health plans on expenditures and utilization.
    Bertko J
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1211-8. PubMed ID: 15230921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.